Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation
Clinical trial NCT03533101 · COMPLETED
Trial details
- NCT number
- NCT03533101
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-25
- Primary completion
- 2019-05-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.